US$ 24.49
glp 1 agonist prescription Are Serious Anesthesia Risks of Semaglutide and Other GLP-1 Agonists Under-Recognized? Case Reports of Retained Solid Gastric Contents in Patients Undergoing Anesthesia GLP-1 Medications for Weight Loss
Description
Oskarsson, M

Rather than conducting a new meta-analysis, the authors synthesize findings from major randomized clinical trials, highlighting outcomes related to glycated hemoglobin (HbA1c), body weight reduction, major adverse cardiovascular events (MACE), and kidney function decline as reported in large cardiovascular outcomes trials (CVOTs), obesity randomized controlled trials, and early-phase clinical development studies

Lim J-H, Kwon S, Seo YJ, Kim YH, Kwon H, Kim YS, Lee H, Kim Y-L, Kim C-D, Park S-H, et al

doi:10.3389/fphar.2023.1113557

However, it remains important to consider that GLP-1 receptor agonists may be limited by unfavorable side effects, especially in the context of PD